These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33737635)

  • 1. Performance of preclinical models in predicting drug-induced liver injury in humans: a systematic review.
    Dirven H; Vist GE; Bandhakavi S; Mehta J; Fitch SE; Pound P; Ram R; Kincaid B; Leenaars CHC; Chen M; Wright RA; Tsaioun K
    Sci Rep; 2021 Mar; 11(1):6403. PubMed ID: 33737635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatotoxicity with thiazolidinediones: is it a class effect?
    Scheen AJ
    Drug Saf; 2001; 24(12):873-88. PubMed ID: 11735645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety data and withdrawal of hepatotoxic drugs.
    Babai S; Auclert L; Le-Louët H
    Therapie; 2021; 76(6):715-723. PubMed ID: 29609830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe cholestatic hepatitis caused by thiazolidinediones: risks associated with substituting rosiglitazone for troglitazone.
    Bonkovsky HL; Azar R; Bird S; Szabo G; Banner B
    Dig Dis Sci; 2002 Jul; 47(7):1632-7. PubMed ID: 12141828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential in vitro hepatotoxicity of troglitazone and rosiglitazone among cryopreserved human hepatocytes from 37 donors.
    Lloyd S; Hayden MJ; Sakai Y; Fackett A; Silber PM; Hewitt NJ; Li AP
    Chem Biol Interact; 2002 Nov; 142(1-2):57-71. PubMed ID: 12399155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of in vitro combination assays of mitochondrial dysfunction and apoptosis for the estimation of potential risk of idiosyncratic drug induced liver injury.
    Goda K; Takahashi T; Kobayashi A; Shoda T; Kuno H; Sugai S
    J Toxicol Sci; 2016; 41(5):605-15. PubMed ID: 27665770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating members of the thiazolidinedione class: a focus on safety.
    Lebovitz HE
    Diabetes Metab Res Rev; 2002; 18 Suppl 2():S23-9. PubMed ID: 11921435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: unified list based on international collaborative work.
    Suzuki A; Andrade RJ; Bjornsson E; Lucena MI; Lee WM; Yuen NA; Hunt CM; Freston JW
    Drug Saf; 2010 Jun; 33(6):503-22. PubMed ID: 20486732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of average molecular weight (AMW) as a useful chemical descriptor to discriminate liver injury-inducing drugs.
    Shimizu Y; Sasaki T; Takeshita JI; Watanabe M; Shizu R; Hosaka T; Yoshinari K
    PLoS One; 2021; 16(6):e0253855. PubMed ID: 34170966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a mouse model of troglitazone-induced liver injury and analysis of its hepatotoxic mechanism.
    Jia R; Oda S; Tsuneyama K; Urano Y; Yokoi T
    J Appl Toxicol; 2019 Nov; 39(11):1541-1556. PubMed ID: 31294483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatotoxicity reports in the FDA adverse event reporting system database: A comparison of drugs that cause injury
    Rana P; Aleo MD; Wen X; Kogut S
    Acta Pharm Sin B; 2021 Dec; 11(12):3857-3868. PubMed ID: 35024312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of liver function in type 2 diabetic patients during clinical trials: evidence that rosiglitazone does not cause hepatic dysfunction.
    Lebovitz HE; Kreider M; Freed MI
    Diabetes Care; 2002 May; 25(5):815-21. PubMed ID: 11978674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiazolidinediones and liver toxicity.
    Scheen AJ
    Diabetes Metab; 2001 Jun; 27(3):305-13. PubMed ID: 11431595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparisons between in vitro whole cell imaging and in vivo zebrafish-based approaches for identifying potential human hepatotoxicants earlier in pharmaceutical development.
    Hill A; Mesens N; Steemans M; Xu JJ; Aleo MD
    Drug Metab Rev; 2012 Feb; 44(1):127-40. PubMed ID: 22242931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling cumulative proportional reporting ratios of drug-induced liver injury in the FDA Adverse Event Reporting System (FAERS) database.
    Brinker AD; Lyndly J; Tonning J; Moeny D; Levine JG; Avigan MI
    Drug Saf; 2013 Dec; 36(12):1169-78. PubMed ID: 24178291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure to develop hepatic injury from rosiglitazone in a patient with a history of troglitazone-induced hepatitis.
    Lenhard MJ; Funk WB
    Diabetes Care; 2001 Jan; 24(1):168-9. PubMed ID: 11194222
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro inhibitory effects of troglitazone and its metabolites on drug oxidation activities of human cytochrome P450 enzymes: comparison with pioglitazone and rosiglitazone.
    Yamazaki H; Suzuki M; Tane K; Shimada N; Nakajima M; Yokoi T
    Xenobiotica; 2000 Jan; 30(1):61-70. PubMed ID: 10659951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Evaluation of Bile Acid Homeostasis in Human Hepatocyte Co-Culture in the Presence of Troglitazone, Pioglitazone, and Acetylsalicylic Acid.
    Chang JH; Sangaraju D; Liu N; Jaochico A; Plise E
    Mol Pharm; 2019 Oct; 16(10):4230-4240. PubMed ID: 31509422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How should patients taking the discontinued diabetes drug troglitazone be managed?
    Reddy SS
    Cleve Clin J Med; 2000 Jun; 67(6):401-2, 455. PubMed ID: 10860221
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.